Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa.
Authors:
- M.A. NaughtonMNM.A. Naughton
- W. TengWTW. Teng
- J.W. RoseJRJ.W. Rose
- D.R. PhillipsDPD.R. Phillips
- L. NannizziLNL. Nannizzi
- A. ArfstenAAA. Arfsten
- A.M. CampbellACA.M. Campbell
- I.F. CharoICI.F. Charo
Open Access
- 1 January 1993
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 268 (2) , 1066-1073
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitroJournal of Medicinal Chemistry, 1991
- Three-dimensional structure of echistatin, the smallest active RGD proteinBiochemistry, 1991
- Solution Structure of Kistrin, a Potent Platelet Aggregation Inhibitor and GP IIb-IIIa AntagonistScience, 1991
- Effect of cyclic RGD peptide on cell adhesion and tumor metastasisBiochemical and Biophysical Research Communications, 1991
- The vitronectin receptor alpha v beta 3 binds fibronectin and acts in concert with alpha 5 beta 1 in promoting cellular attachment and spreading on fibronectin.Journal of Cell Biology, 1990
- Batroxostatin, an Arg-Gly-Asp-containing peptide from Bothrops atrox, is a potent inhibitor of platelet aggregation and cell interaction with fibronectinBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1990
- Differential structural requirements for fibrinogen binding to platelets and to endothelial cells.Journal of Cell Biology, 1989
- Trigramin, an RGD-containing peptide from snake venom, inhibits cell-substratum adhesion of human melanoma cellsExperimental Cell Research, 1988
- New Perspectives in Cell Adhesion: RGD and IntegrinsScience, 1987
- Further enhancement of analgesic activity: enkephalin analogs with terminal guanidino groupFEBS Letters, 1980